THE TOXIC EFFECT OF HYPERGLYCAEMIA IN THE PATHOGENESIS OF SELECTED CHRONIC COMPLICATIONS OF DIABETES MELLITUS: A MINI-REVIEW
Slovak Journal of Animal Science · 2022
DOI: 10.36547/sjas.796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Slovak Journal of Animal Science, 2022. Verfasst von Jana HRNKOVÁ und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus is a group of metabolic diseases that, due to the long-term pathological effect of hyperglycaemia on tissues, lead to the development of typical chronic organ complications. Chronic hyperglycaemia leads to increased activity of the polyol pathway with subsequent accumulation of sorbitol and fructose, increased formation and accumulation of end products of advanced glycation, alteration of protein kinase C activity, excessive formation of reactive oxygen species and associated high level of oxidative stress. One of the most feared complications of diabetes mellitus is vision impairment and blindness. In this review, we address the most important metabolic pathways leading to the development of diabetic retinopathy and diabetic cataract, the ocular complications of diabetes with the greatest risk of vision loss.
Zitieren
APA
HRNKOVÁ, J., DUPÁK, R., & CAPCAROVÁ, M. (2022). THE TOXIC EFFECT OF HYPERGLYCAEMIA IN THE PATHOGENESIS OF SELECTED CHRONIC COMPLICATIONS OF DIABETES MELLITUS: A MINI-REVIEW. Slovak Journal of Animal Science. https://doi.org/10.36547/sjas.796
Vancouver
HRNKOVÁ J, DUPÁK R, CAPCAROVÁ M. THE TOXIC EFFECT OF HYPERGLYCAEMIA IN THE PATHOGENESIS OF SELECTED CHRONIC COMPLICATIONS OF DIABETES MELLITUS: A MINI-REVIEW. Slovak Journal of Animal Science. 2022. doi:10.36547/sjas.796
BibTeX
@article{HRNKOV2022,
author = {HRNKOVÁ, Jana and DUPÁK, Rudolf and CAPCAROVÁ, Marcela},
title = {THE TOXIC EFFECT OF HYPERGLYCAEMIA IN THE PATHOGENESIS OF SELECTED CHRONIC COMPLICATIONS OF DIABETES MELLITUS: A MINI-REVIEW},
journal = {Slovak Journal of Animal Science},
year = {2022},
doi = {10.36547/sjas.796}
}
EUVIMED